CClinicalTrials.gg
TerminatedNCT03261817PEPSYV@SIUpdated Mar 22, 2022

A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders

An interventional study of Physical activity (APA) and Health Education program (HE) in Schizophrenia, Physical Activity and Schizo Affective Disorder, sponsored by University Hospital, Caen. Terminated at 1 site in France. Open to participants aged 18 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-03-22.

Sponsored by University Hospital, Caen · Not applicable, Interventional, and Supportive care

Why this study was terminated
No financial support
Phase
Not applicable
Study type
Interventional
Enrollment
62
Allocation
Randomized
Ages
18 Years to 60 Years
Sex
All
01

Study summary

In this study, an APA program by web (e-APA) will be offered to two groups of participants (21 patients and 21 healthy volunteers (HV)) in remote video (use of the SAPATIC (Santé Activités Physiques Adaptées utilisant les Technologies de l'Information et de la Communication) platform developed by the company V@SI). At the same time, two control groups, a group of 21 patients and a group of 21 HV will undergo an health education program (HE) through the collaborative SAPATIC health platform of V@Si and will constitute the control groups. The content of the APA sessions will be administered by V@Si. This program offers content aimed to improve aerobic capacity and muscular strength while relying on the motivation of the participants

Read the detailed description

The main objective is to demonstrate that APA can improve cerebral plasticity in patients with schizophrenic or schizoaffective disorders (SCZ), reflected by an increase in the overall volume of hippocampus.

The secondary objectives will also be to assess the impact of APA on the SCZ compared to the HV:

  1. on other cerebral variables (changes in the different subregions of the hippocampus (Cornu Ammonis (CA: CA1,CA2-3-4), subiculum and dentate gyrus), cortical thickness, N-acetyl aspartate (NAA) and glutamate as well as changes in the white matter through the diffusion markers (fractional anisotropy, radial diffusivity and mean diffusivity in the frontomedial-hippocampal fibers) and cerebral irrigation
  2. on physiological variables (neuromuscular, cardiovascular (heart rate variability) and aerobic)
  3. on cognitive variables by measuring working memory, episodic memory, attentional and executive functions
  4. on circadian rhythms (temperature, actimetry and wake-sleep cycle)
  5. on the clinical status of patients (severity of symptoms, quality of life, level of activity and physical abilities).
  6. on biological variables (fasting glucose, triglycerides, total cholesterol, High-density lipoprotein cholesterol (HDLc), Low-density lipoprotein cholesterol (LDLc)
02

Conditions studied

  • Schizophrenia
  • Physical Activity
  • Schizo Affective Disorder

Keywords

  • web
  • brain imaging
  • heart rate variability
  • circadian cycles
  • cognition
  • well-being
  • hippocampus
  • N acetyl aspartate
  • white matter
  • physical activity
03

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Patients:

  • Be over 18 years of age and under 60 years of age
  • with schizophrenia or schizoaffective disorder according to DSM-IV (Diagnostic and Statistical Manual of Mental Disorders, 4th edition) criteria established with a semi-structured interview (Mini International Neuropsychiatric Interview, French version 5.0.0).
  • The possibility of receiving each of the 2 interventions (APA or HE)
  • No change in psychotropic drugs (antidepressants, antipsychotics or mood regulators) during the 2 months prior to inclusion for patients.
  • Collecting the signature of informed consent.
  • The need to be affiliated to a medical welfare
  • The agreement of the guardian or trustee in case of a protected major

Healthy Volunteers:

  • between 18 and 60 years old
  • The possibility of receiving each of the 2 interventions (APA or HE)
  • Collecting the signature of informed consent.
  • The need to be affiliated to a medical welfare

Exclusion criteria

Exclusion Criteria:

Patients with only one of the non-inclusion criteria may not be eligible to participate in the research. These criteria are:

  • Age under 18 or over 60 years old
  • Pregnancy
  • The inclusion of the patient in another biomedical research protocol (during the present study)
  • Patients with progressive neurological disease
  • Patients with contraindications to MRI (including electronic or metal implants)
  • Patients who refused to wear earplugs during the MRI examination
  • Patients with a physical contraindication to physical activity (moderate to severe heart failure, severe valvular disease, unstable coronary disease, acute pulmonary embolism or untreated deep venous thrombosis, uncontrolled hypertension, pulmonary arterial hypertension, treaty)
  • Neuromuscular pathologies, severe sensory and / or motor neuropathy
  • Rheumatic and articular pathologies; Rheumatologic / orthopedic problems or bone lesions at risk of fracture contraindicating physical activity
  • History of stroke or myocardial infarction less than 6 months old at the selection visit

Healthy Volunteers

Participants with only one of the non-inclusion criteria may not be eligible to participate in the research. These criteria are:

  • Age under 18 or over 60 years old
  • Pregnancy
  • Inclusion of the participant in another biomedical research protocol (during this study)
  • Participants with progressive neurological disease
  • Participants with a contraindication to MRI (including electronic or metal implants)
  • Participants refused to wear ear plugs during the MRI examination
  • Participants with life-long schizophrenia or schizoaffective disorder according to the DSM-IV criteria established with a semi-structured interview (Mini International Neuropsychiatric Interview, MINI; French version 5.0.0).
  • Presence of cardiovascular pathologies contraindicating physical activity (moderate to severe heart failure, severe valvular disease, unstable coronary disease, acute pulmonary embolism or untreated deep venous thrombosis, uncontrolled hypertension, pulmonary arterial hypertension, rhythm disorder untreated)
  • Neuromuscular pathologies, severe sensory and / or motor neuropathy
  • Rheumatic and articular diseases, rheumatological / orthopedic problems or fracture risk bone lesions
  • History of stroke or myocardial infarction less than 6 months old at the selection visit
04

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
62 participants (actual)

Study arms

  • Experimental
    APA in patients

    patients receiving physical activity (APA) by web during 16 weeks with 2 sessions a week

    Behavioral: Physical activity (APA)

  • Sham comparator
    HE in patients

    patients receiving Health education program (HE) by web during 16 weeks with 2 sessions a week

    Behavioral: Health Education program (HE)

  • Active comparator
    APA in healthy volunteer controls

    Healthy volunteers receiving physical activity (APA) by web during 16 weeks with 2 sessions a week

    Behavioral: Physical activity (APA)

  • Sham comparator
    HE in healthy volunteer controls

    Healthy volunteers receiving Health education program (HE) by web during 16 weeks with 2 sessions a week

    Behavioral: Health Education program (HE)

Interventions

  • BehavioralPhysical activity (APA)

    2 sessions a week of 1 hour during 16 weeks. APA exercises by web will be aerobic type associated with muscle toning program; Activities will combine relaxation techniques, body expression and muscle relaxation (yoga, stretching, relaxation, step etc ...). The intensity of the activities will be individualized for each participant according to his/her physical condition

  • BehavioralHealth Education program (HE)

    2 sessions a week of 1 hour during 16 weeks HE by web will be delivered and was composed of information on the main mental disorders, the benefits of physical activity, healthy lifestyle (dietary balance, sleep cycle, stress management), alcohol, drug, tobacco and cardiovascular risk factors

05

What researchers measure

Primary outcomes

  1. hippocampal volumes

    The primary endpoint is the right and left hippocampal volumes

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

Secondary outcomes

  1. Cerebral variables

    changes in the different subregions of the hippocampus (CA1, CA2-3-4, subiculum and dentate gyrus, cortical thickness, N-acetyl aspartate (NAA) and glutamate as well as changes in the white matter through the diffusion markers (fractional anisotropy, radial diffusivity and mean diffusivity in the frontomedial-hippocampal fibers) and cerebral irrigation

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

  2. Physiological variables

    neuromuscular, cardiovascular (heart rate variability) and aerobic (VO2)

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

  3. Circadian rhythms

    temperature, actimetry and wake-sleep cycle

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

  4. Clinical status

    severity of symptoms, quality of life, level of activity and physical abilities

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

  5. Biological variables

    fasting glucose, triglycerides, total cholesterol, HDLc, LDLc

    Time frame: at Day 127 +/- 8 days or after 10 sessions of APA if premature cessation of treatment

06

Study locations

1 site
  • Caen University Hospital
    Caen, 14033, France
07

References and documents

Publications

  • Trehout M, Leroux E, Bigot L, Jego S, Leconte P, Reboursiere E, Morello R, Chapon PA, Herbinet A, Quarck G, Dollfus S. A web-based adapted physical activity program (e-APA) versus health education program (e-HE) in patients with schizophrenia and healthy volunteers: study protocol for a randomized controlled trial (PEPSY V@Si). Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):325-337. doi: 10.1007/s00406-020-01140-z. Epub 2020 May 26. PubMed 32458107 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03261817
Lead sponsor
University Hospital, Caen
Collaborators
Centre Hospitalier du Rouvray
Responsible party
Sponsor
First posted
Aug 25, 2017
Start date
Sep 29, 2017
Primary completion
Jun 22, 2021
Completion
Jun 22, 2021
Last update
Mar 22, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is terminated, as verified in Jul 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion